Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:pyranocoumarins'
(id=6720197 ; fe=en:pyranocoumarins ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1319 creation date=2017-06-21 touchdate=2025-07-24 22:58:15.000)
≈ 42 relations sortantes

  1. en:pyranocoumarins -- r_associated #0: 42 / 1 -> en:immunology aspects
    n1=en:pyranocoumarins | n2=en:immunology aspects | rel=r_associated | relid=0 | w=42
  2. en:pyranocoumarins -- r_associated #0: 41 / 0.976 -> en:therapeutic use - qualifier
    n1=en:pyranocoumarins | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=41
  3. en:pyranocoumarins -- r_associated #0: 37 / 0.881 -> en:esculin
    n1=en:pyranocoumarins | n2=en:esculin | rel=r_associated | relid=0 | w=37
  4. en:pyranocoumarins -- r_associated #0: 35 / 0.833 -> en:calanolide a
    n1=en:pyranocoumarins | n2=en:calanolide a | rel=r_associated | relid=0 | w=35
  5. en:pyranocoumarins -- r_associated #0: 35 / 0.833 -> en:calanolide e2
    n1=en:pyranocoumarins | n2=en:calanolide e2 | rel=r_associated | relid=0 | w=35
  6. en:pyranocoumarins -- r_associated #0: 35 / 0.833 -> en:coumestrol
    n1=en:pyranocoumarins | n2=en:coumestrol | rel=r_associated | relid=0 | w=35
  7. en:pyranocoumarins -- r_associated #0: 35 / 0.833 -> en:iridoids
    n1=en:pyranocoumarins | n2=en:iridoids | rel=r_associated | relid=0 | w=35
  8. en:pyranocoumarins -- r_associated #0: 35 / 0.833 -> en:umbelliferones
    n1=en:pyranocoumarins | n2=en:umbelliferones | rel=r_associated | relid=0 | w=35
  9. en:pyranocoumarins -- r_associated #0: 34 / 0.81 -> en:aspects of radiation effects
    n1=en:pyranocoumarins | n2=en:aspects of radiation effects | rel=r_associated | relid=0 | w=34
  10. en:pyranocoumarins -- r_associated #0: 34 / 0.81 -> en:in cerebrospinal fluid
    n1=en:pyranocoumarins | n2=en:in cerebrospinal fluid | rel=r_associated | relid=0 | w=34
  11. en:pyranocoumarins -- r_associated #0: 34 / 0.81 -> en:nigericin
    n1=en:pyranocoumarins | n2=en:nigericin | rel=r_associated | relid=0 | w=34
  12. en:pyranocoumarins -- r_associated #0: 34 / 0.81 -> en:patulin
    n1=en:pyranocoumarins | n2=en:patulin | rel=r_associated | relid=0 | w=34
  13. en:pyranocoumarins -- r_associated #0: 34 / 0.81 -> en:zanamivir
    n1=en:pyranocoumarins | n2=en:zanamivir | rel=r_associated | relid=0 | w=34
  14. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:10-chloromethyl-11-demethyl-12-oxocalanolide a
    n1=en:pyranocoumarins | n2=en:10-chloromethyl-11-demethyl-12-oxocalanolide a | rel=r_associated | relid=0 | w=32
  15. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:11-demethylcalanolide a
    n1=en:pyranocoumarins | n2=en:11-demethylcalanolide a | rel=r_associated | relid=0 | w=32
  16. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:benzopyrans
    n1=en:pyranocoumarins | n2=en:benzopyrans | rel=r_associated | relid=0 | w=32
  17. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:chemical synthesis
    n1=en:pyranocoumarins | n2=en:chemical synthesis | rel=r_associated | relid=0 | w=32
  18. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:chromonar
    n1=en:pyranocoumarins | n2=en:chromonar | rel=r_associated | relid=0 | w=32
  19. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:coumarins
    n1=en:pyranocoumarins | n2=en:coumarins | rel=r_associated | relid=0 | w=32
  20. en:pyranocoumarins -- r_associated #0: 32 / 0.762 -> en:isocoumarins
    n1=en:pyranocoumarins | n2=en:isocoumarins | rel=r_associated | relid=0 | w=32
  21. en:pyranocoumarins -- r_associated #0: 31 / 0.738 -> en:10-chloromethyl-11-demethyl-12-oxo-calanolide a
    n1=en:pyranocoumarins | n2=en:10-chloromethyl-11-demethyl-12-oxo-calanolide a | rel=r_associated | relid=0 | w=31
  22. en:pyranocoumarins -- r_associated #0: 31 / 0.738 -> en:calanolides
    n1=en:pyranocoumarins | n2=en:calanolides | rel=r_associated | relid=0 | w=31
  23. en:pyranocoumarins -- r_associated #0: 31 / 0.738 -> en:dihydropyranocoumarin d2
    n1=en:pyranocoumarins | n2=en:dihydropyranocoumarin d2 | rel=r_associated | relid=0 | w=31
  24. en:pyranocoumarins -- r_associated #0: 31 / 0.738 -> en:furanocoumarin
    n1=en:pyranocoumarins | n2=en:furanocoumarin | rel=r_associated | relid=0 | w=31
  25. en:pyranocoumarins -- r_associated #0: 30 / 0.714 -> en:calanolide b
    n1=en:pyranocoumarins | n2=en:calanolide b | rel=r_associated | relid=0 | w=30
  26. en:pyranocoumarins -- r_associated #0: 30 / 0.714 -> en:mupirocin
    n1=en:pyranocoumarins | n2=en:mupirocin | rel=r_associated | relid=0 | w=30
  27. en:pyranocoumarins -- r_associated #0: 30 / 0.714 -> en:pyrans
    n1=en:pyranocoumarins | n2=en:pyrans | rel=r_associated | relid=0 | w=30
  28. en:pyranocoumarins -- r_associated #0: 29 / 0.69 -> en:exposure as collected domain
    n1=en:pyranocoumarins | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=29
  29. en:pyranocoumarins -- r_associated #0: 29 / 0.69 -> en:metabolic aspects
    n1=en:pyranocoumarins | n2=en:metabolic aspects | rel=r_associated | relid=0 | w=29
  30. en:pyranocoumarins -- r_associated #0: 29 / 0.69 -> en:pyran copolymer
    n1=en:pyranocoumarins | n2=en:pyran copolymer | rel=r_associated | relid=0 | w=29
  31. en:pyranocoumarins -- r_associated #0: 29 / 0.69 -> en:pyrones
    n1=en:pyranocoumarins | n2=en:pyrones | rel=r_associated | relid=0 | w=29
  32. en:pyranocoumarins -- r_associated #0: 29 / 0.69 -> en:scuteflorin a
    n1=en:pyranocoumarins | n2=en:scuteflorin a | rel=r_associated | relid=0 | w=29
  33. en:pyranocoumarins -- r_associated #0: 27 / 0.643 -> en:4-hydroxycoumarins
    n1=en:pyranocoumarins | n2=en:4-hydroxycoumarins | rel=r_associated | relid=0 | w=27
  34. en:pyranocoumarins -- r_associated #0: 27 / 0.643 -> en:agonists
    n1=en:pyranocoumarins | n2=en:agonists | rel=r_associated | relid=0 | w=27
  35. en:pyranocoumarins -- r_associated #0: 27 / 0.643 -> en:aminocoumarins
    n1=en:pyranocoumarins | n2=en:aminocoumarins | rel=r_associated | relid=0 | w=27
  36. en:pyranocoumarins -- r_associated #0: 27 / 0.643 -> en:aurovertins
    n1=en:pyranocoumarins | n2=en:aurovertins | rel=r_associated | relid=0 | w=27
  37. en:pyranocoumarins -- r_associated #0: 26 / 0.619 -> en:calanolide c
    n1=en:pyranocoumarins | n2=en:calanolide c | rel=r_associated | relid=0 | w=26
  38. en:pyranocoumarins -- r_associated #0: 26 / 0.619 -> en:glaucarubin
    n1=en:pyranocoumarins | n2=en:glaucarubin | rel=r_associated | relid=0 | w=26
  39. en:pyranocoumarins -- r_associated #0: 26 / 0.619 -> en:pharmacokinetic aspects
    n1=en:pyranocoumarins | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=26
  40. en:pyranocoumarins -- r_associated #0: 26 / 0.619 -> en:poisoning aspects
    n1=en:pyranocoumarins | n2=en:poisoning aspects | rel=r_associated | relid=0 | w=26
  41. en:pyranocoumarins -- r_associated #0: 24 / 0.571 -> en:mechanism of action qualifier
    n1=en:pyranocoumarins | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=24
  42. en:pyranocoumarins -- r_associated #0: 20 / 0.476 -> coumestrol
    n1=en:pyranocoumarins | n2=coumestrol | rel=r_associated | relid=0 | w=20
≈ 46 relations entrantes

  1. coumestrol --- r_associated #0: 78 --> en:pyranocoumarins
    n1=coumestrol | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=78
  2. en:coumestrol --- r_associated #0: 75 --> en:pyranocoumarins
    n1=en:coumestrol | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=75
  3. en:aurovertins --- r_associated #0: 43 --> en:pyranocoumarins
    n1=en:aurovertins | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=43
  4. en:10-chloromethyl-11-demethyl-12-oxocalanolide a --- r_associated #0: 41 --> en:pyranocoumarins
    n1=en:10-chloromethyl-11-demethyl-12-oxocalanolide a | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=41
  5. en:11-demethylcalanolide a --- r_associated #0: 35 --> en:pyranocoumarins
    n1=en:11-demethylcalanolide a | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=35
  6. en:nigericin --- r_associated #0: 35 --> en:pyranocoumarins
    n1=en:nigericin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=35
  7. en:calanolides --- r_associated #0: 34 --> en:pyranocoumarins
    n1=en:calanolides | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=34
  8. en:dihydropyranocoumarin d2 --- r_associated #0: 34 --> en:pyranocoumarins
    n1=en:dihydropyranocoumarin d2 | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=34
  9. en:scuteflorin a --- r_associated #0: 34 --> en:pyranocoumarins
    n1=en:scuteflorin a | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=34
  10. en:calanolide b --- r_associated #0: 32 --> en:pyranocoumarins
    n1=en:calanolide b | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=32
  11. en:calanolide e2 --- r_associated #0: 32 --> en:pyranocoumarins
    n1=en:calanolide e2 | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=32
  12. en:pharmacokinetic aspects --- r_associated #0: 31 --> en:pyranocoumarins
    n1=en:pharmacokinetic aspects | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=31
  13. en:aminocoumarins --- r_associated #0: 30 --> en:pyranocoumarins
    n1=en:aminocoumarins | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=30
  14. en:metabolic aspects --- r_associated #0: 30 --> en:pyranocoumarins
    n1=en:metabolic aspects | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=30
  15. en:umbelliferones --- r_associated #0: 30 --> en:pyranocoumarins
    n1=en:umbelliferones | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=30
  16. en:agonists --- r_associated #0: 29 --> en:pyranocoumarins
    n1=en:agonists | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=29
  17. en:iridoids --- r_associated #0: 29 --> en:pyranocoumarins
    n1=en:iridoids | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=29
  18. en:mechanism of action qualifier --- r_associated #0: 29 --> en:pyranocoumarins
    n1=en:mechanism of action qualifier | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=29
  19. en:4-hydroxycoumarins --- r_associated #0: 28 --> en:pyranocoumarins
    n1=en:4-hydroxycoumarins | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=28
  20. en:in cerebrospinal fluid --- r_associated #0: 28 --> en:pyranocoumarins
    n1=en:in cerebrospinal fluid | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=28
  21. en:poisoning aspects --- r_associated #0: 28 --> en:pyranocoumarins
    n1=en:poisoning aspects | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=28
  22. en:pyrones --- r_associated #0: 28 --> en:pyranocoumarins
    n1=en:pyrones | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=28
  23. en:therapeutic use - qualifier --- r_associated #0: 28 --> en:pyranocoumarins
    n1=en:therapeutic use - qualifier | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=28
  24. en:benzopyrans --- r_associated #0: 27 --> en:pyranocoumarins
    n1=en:benzopyrans | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=27
  25. en:pyrans --- r_associated #0: 27 --> en:pyranocoumarins
    n1=en:pyrans | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=27
  26. en:zanamivir --- r_associated #0: 27 --> en:pyranocoumarins
    n1=en:zanamivir | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=27
  27. en:calanolide a --- r_associated #0: 26 --> en:pyranocoumarins
    n1=en:calanolide a | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=26
  28. en:calanolide c --- r_associated #0: 26 --> en:pyranocoumarins
    n1=en:calanolide c | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=26
  29. en:isocoumarins --- r_associated #0: 26 --> en:pyranocoumarins
    n1=en:isocoumarins | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=26
  30. en:patulin --- r_associated #0: 26 --> en:pyranocoumarins
    n1=en:patulin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=26
  31. en:coumarins --- r_associated #0: 25 --> en:pyranocoumarins
    n1=en:coumarins | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=25
  32. en:pyran copolymer --- r_associated #0: 25 --> en:pyranocoumarins
    n1=en:pyran copolymer | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=25
  33. en:chemical synthesis --- r_associated #0: 24 --> en:pyranocoumarins
    n1=en:chemical synthesis | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=24
  34. en:aspects of radiation effects --- r_associated #0: 23 --> en:pyranocoumarins
    n1=en:aspects of radiation effects | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=23
  35. en:esculin --- r_associated #0: 23 --> en:pyranocoumarins
    n1=en:esculin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=23
  36. en:exposure as collected domain --- r_associated #0: 23 --> en:pyranocoumarins
    n1=en:exposure as collected domain | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=23
  37. en:immunology aspects --- r_associated #0: 23 --> en:pyranocoumarins
    n1=en:immunology aspects | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=23
  38. en:chromonar --- r_associated #0: 22 --> en:pyranocoumarins
    n1=en:chromonar | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=22
  39. en:glaucarubin --- r_associated #0: 22 --> en:pyranocoumarins
    n1=en:glaucarubin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=22
  40. en:10-chloromethyl-11-demethyl-12-oxo-calanolide a --- r_associated #0: 21 --> en:pyranocoumarins
    n1=en:10-chloromethyl-11-demethyl-12-oxo-calanolide a | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=21
  41. en:furanocoumarin --- r_associated #0: 21 --> en:pyranocoumarins
    n1=en:furanocoumarin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=21
  42. en:mupirocin --- r_associated #0: 21 --> en:pyranocoumarins
    n1=en:mupirocin | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=21
  43. esculine --- r_associated #0: 10 --> en:pyranocoumarins
    n1=esculine | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=10
  44. mupirocine --- r_associated #0: 10 --> en:pyranocoumarins
    n1=mupirocine | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=10
  45. patuline --- r_associated #0: 10 --> en:pyranocoumarins
    n1=patuline | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=10
  46. zanamivir --- r_associated #0: 10 --> en:pyranocoumarins
    n1=zanamivir | n2=en:pyranocoumarins | rel=r_associated | relid=0 | w=10
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr